ALPHA TRIBE

Suven Life Sciences LimitedUpdates, 30-07-2026: General Updates

30-07-2026 | 11:58 am

Suven Life Sciences, an R&D specialist, reported FY26 turnover of ₹7.11 Cr and net worth of ₹1,503.37 Cr. Employee well-being spending increased to 16.47% of revenue. Environmental performance indicates higher energy/GHG/water intensity per rupee of turnover, though waste intensity decreased. 90% inputs are sustainably sourced. No regulatory fines or complaints were reported.

No comments yet. Be the first to comment!

All announcements from Suven Life Sciences Limited